FibroGen Inc (FGEN)
1.365
+0.20
(+17.67%)
USD |
NASDAQ |
May 07, 16:00
1.35
-0.02
(-1.10%)
After-Hours: 20:00
FibroGen Price: 1.365 for May 7, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 1.20 | 1.26 | 1.15 | 1.16 | 954942.0 |
May 03, 2024 | 1.12 | 1.220 | 1.11 | 1.14 | 780857.0 |
May 02, 2024 | 1.19 | 1.23 | 1.12 | 1.13 | 921242.0 |
May 01, 2024 | 1.12 | 1.217 | 1.09 | 1.17 | 1.089M |
Apr 30, 2024 | 1.05 | 1.16 | 1.03 | 1.12 | 1.123M |
Apr 29, 2024 | 1.06 | 1.17 | 1.02 | 1.09 | 1.202M |
Apr 26, 2024 | 1.04 | 1.06 | 0.9754 | 1.04 | 653815.0 |
Apr 25, 2024 | 0.95 | 1.025 | 0.9010 | 1.02 | 1.259M |
Apr 24, 2024 | 1.06 | 1.098 | 0.9327 | 0.9843 | 2.171M |
Apr 23, 2024 | 1.15 | 1.26 | 1.05 | 1.07 | 1.349M |
Apr 22, 2024 | 1.15 | 1.17 | 1.08 | 1.14 | 803876.0 |
Apr 19, 2024 | 1.16 | 1.18 | 1.05 | 1.15 | 1.313M |
Apr 18, 2024 | 1.26 | 1.29 | 1.14 | 1.17 | 1.278M |
Apr 17, 2024 | 1.30 | 1.33 | 1.24 | 1.27 | 1.031M |
Apr 16, 2024 | 1.28 | 1.35 | 1.25 | 1.30 | 863694.0 |
Apr 15, 2024 | 1.30 | 1.37 | 1.24 | 1.31 | 1.265M |
Apr 12, 2024 | 1.35 | 1.35 | 1.23 | 1.30 | 1.140M |
Apr 11, 2024 | 1.45 | 1.465 | 1.35 | 1.36 | 1.162M |
Apr 10, 2024 | 1.49 | 1.51 | 1.36 | 1.43 | 1.356M |
Apr 09, 2024 | 1.62 | 1.63 | 1.485 | 1.51 | 1.014M |
Apr 08, 2024 | 1.63 | 1.69 | 1.56 | 1.63 | 1.198M |
Apr 05, 2024 | 1.56 | 1.695 | 1.51 | 1.62 | 1.620M |
Apr 04, 2024 | 1.41 | 1.815 | 1.385 | 1.58 | 4.161M |
Apr 03, 2024 | 2.14 | 2.15 | 1.180 | 1.47 | 10.34M |
Apr 02, 2024 | 2.28 | 2.33 | 2.10 | 2.16 | 932124.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.3801
Minimum
Nov 10 2023
55.72
Maximum
Feb 12 2021
22.88
Average
17.82
Median
May 17 2023
Price Benchmarks
Annovis Bio Inc | 5.31 |
Emergent BioSolutions Inc | 4.41 |
Vertex Pharmaceuticals Inc | 410.19 |
Geron Corp | 3.865 |
Regeneron Pharmaceuticals Inc | 970.26 |
Price Related Metrics
PS Ratio | 0.8989 |
Earnings Yield | -214.7% |
Market Cap | 134.82M |